

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
The consolidated financial statement of ono pharmaceutical co. Ltd. And its subsidiaries as of march 31, 2018. The balance sheet, showing current and non-current assets, current and non-current liabilities, and equity. The assets include cash and cash equivalents, trade and other receivables, marketable securities, inventories, property, plant, and equipment, intangible assets, investment securities, investments in associates, and other financial assets. The liabilities consist of trade and other payables, borrowings, other financial liabilities, income taxes payable, provisions, and other current and non-current liabilities.
Typology: Study notes
1 / 2
This page cannot be seen from the preview
Don't miss anything!
Fiscal Year ended March 31, 2018
Ono Pharmaceutical Co., Ltd. and Consolidated Subsidiaries
Current assets Cash and cash equivalents ¥ 146,323 ¥ 65,273 $ 615, Trade and other receivables 73,255 (^) 77,577 731, Marketable securities 17,560 (^) 9,670 91, Other financial assets (^819) 10,833 102, Inventories (^) 25,334 31,290 295, Other current assets 7,742 14,821 139, Total current assets (^) 271,033 209,464 1,976,
Non-current assets Property, plant, and equipment 83,659 94,321 889, Intangible assets 45,237 55,715 525, Investment securities 176,573 (^) 188,803 1,781, Investments in associates (^114) 116 1, Other financial assets 26,836 46,685 440, Deferred tax assets 10,739 10,192 96, Other non-current assets 3,271 3,929 37, Total non-current assets 346,428 399,761 3,771,
Total assets ¥ 617,461 ¥ 609,226 $ 5,747,
Millions of yen Thousands of US$
Current liabilities
Trade and other payables ¥ 30,905 ¥ 34,015 $ 320, Borrowings 423 392 3, Other financial liabilities 5,814 3,756 35, Income taxes payable 24,777 8,742 82, Provisions 6,086 (^) 11,696 110, Other current liabilities 14,928 9,869 93, Total current liabilities 82,933 68,469 645,
Non-current liabilities
Borrowings 542 320 3, Other financial liabilities 11 8 74 Retirement benefit liabilities 2,805 (^) 3,856 36, Provisions 30 30 283 Deferred tax liabilities 881 1,016 9, Long-term advances received 5,276 5,095 48, Other non-current liabilities 772 814 7, Total non-current liabilities (^) 10,316 11,138 105, Total liabilities 93,250 79,607 751,
Equity
Share capital 17,358 17,358 163, Capital reserves 17,144 17,175 162, Treasury shares (59,382) (^) (38,148) (359,884) Other components of equity 51,752 68,021 641, Retained earnings 492,237 459,985 4,339,
Non-controlling interests 5,101 5,228 49, Total equity 524,211 (^) 529,619 4,996,
Total liabilities and equity ¥ 617,461 ¥ 609,226 $ 5,747,
Millions of yen Thousands of US$
Equity attributable to owners of the parent company